Nutragini Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1627.16%
(FY 2021)
- Profit 195.89%
(FY 2021)
- Ebitda 194.88%
(FY 2021)
- Net Worth 103.79%
(FY 2021)
- Total Assets -10.85%
(FY 2021)
About Nutragini Lifesciences
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jobandeep Sandhu and Ram Saroop serve as directors at the Company.
- CIN/LLPIN
U51220PB2019PTC049439
- Company No.
049439
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nutragini Lifesciences Private Limited offer?
Nutragini Lifesciences Private Limited offers a wide range of products and services, including Prefabricated Houses & Structures, Portable Cabins, Shower Panels & Accessories, Shower Enclosure & Cabins.
Who are the key members and board of directors at Nutragini Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jobandeep Sandhu  | Director | 01-Dec-2021 | Current |
| Ram Saroop | Director | 11-Dec-2021 | Current |
Financial Performance of Nutragini Lifesciences.
Nutragini Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1627.16% increase. The company also saw a substantial improvement in profitability, with a 195.89% increase in profit. The company's net worth Soared by an impressive increase of 103.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutragini Lifesciences?
In 2021, Nutragini Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nutragini Lifesciences?
Unlock and access historical data on people associated with Nutragini Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutragini Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutragini Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
